These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1780535)

  • 21. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide.
    Yu LC; Shenoy S; Ward K; Warrier RP
    Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Commenting on "Vulvar langerhans cell histocytosis: a case report and review of the literature" by Santillan et al. 91:241-246.
    Powell JL; Otis CN
    Gynecol Oncol; 2004 Jun; 93(3):719; author reply 719. PubMed ID: 15196873
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
    Miura T; Nakamura M; Tsunematsu Y; Fujimoto J; Meguro T; Yamada K
    Acta Paediatr Jpn; 1993 Apr; 35(2):148-50. PubMed ID: 8503273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC.
    Culić S; Jakobson A; Culić V; Kuzmić I; Sćukanec-Spoljar M; Primorac D
    Pediatr Hematol Oncol; 2001 Jun; 18(4):291-4. PubMed ID: 11400655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retrospective analysis of the results of the treatment of children with histiocytosis].
    Januszkiewicz D; Nowak T
    Acta Haematol Pol; 1991; 22(2):297-302. PubMed ID: 1841502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Langerhans cell histiocytosis--evolution and current approaches.
    Ladisch S; Gadner H
    Br J Cancer Suppl; 1994 Sep; 23():S41-6. PubMed ID: 8075005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Langerhans cell histiocytosis in an adult.
    Rees J; Paterson AW
    Br J Oral Maxillofac Surg; 2009 Jan; 47(1):52-3. PubMed ID: 18514981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH).
    Lopes LF; de Camargo B
    Med Pediatr Oncol; 1999 Apr; 32(4):315. PubMed ID: 10102032
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of Langerhans-cell histiocytosis by oral cyclosporin A and topical nitrogen mustard].
    Forssman T; Fluhr J; Djawari D; Gloor M; Rumpelt HJ
    Ann Dermatol Venereol; 1994; 121(10):734. PubMed ID: 7793767
    [No Abstract]   [Full Text] [Related]  

  • 30. Unusual skin tumors in Langerhans' cell histiocytosis.
    Santhosh-Kumar CR; al Momen A; Ajarim DS; Shipkey FH; Kyriacou KC
    Arch Dermatol; 1990 Dec; 126(12):1617-20. PubMed ID: 2256687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Langerhans cell histiocytosis: treatment failure with imatinib.
    Wagner C; Mohme H; Krömer-Olbrisch T; Stadler R; Goerdt S; Kurzen H
    Arch Dermatol; 2009 Aug; 145(8):949-50. PubMed ID: 19687437
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sequential trials in initial chemotherapy of advanced tumors of the upper aero-digestive system. Cis-diamminedichloroplatinum (DDP) versus DDP-etoposide (VP16)].
    Coninx P; Nasca S; Jezekova D; Marechal F; Garbe E; Legros M; Cattan A
    Bull Cancer; 1986; 73(1):85-8. PubMed ID: 3779127
    [No Abstract]   [Full Text] [Related]  

  • 33. Langerhans' cell histiocytosis.
    Mortazavi H; Ehsani A; Namazi MR; Hosseini M
    Dermatol Online J; 2002 Oct; 8(2):18. PubMed ID: 12546773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive treatment for chemotherapy-resistant multisystem Langerhans cell histiocytosis.
    Minkov M; Grois N; Braier J; Rosso D; Aricò M; Broadbent V; Gadner H; Ladisch S;
    Med Pediatr Oncol; 2003 Apr; 40(4):253-6. PubMed ID: 12555257
    [No Abstract]   [Full Text] [Related]  

  • 35. Langerhans cell histiocytosis of vulva.
    Fernandez Flores A; Mallo S
    Dermatol Online J; 2006 Jan; 12(1):15. PubMed ID: 16638383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H;
    Med Pediatr Oncol; 2002 Dec; 39(6):581-5. PubMed ID: 12376981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VP-16 and the treatment of histiocytosis.
    Gadner H; Ladisch S; Aricó M; Broadbent V; Jakobson A; Komp D; Nicholson S
    Eur J Pediatr; 1994 May; 153(5):389. PubMed ID: 8033933
    [No Abstract]   [Full Text] [Related]  

  • 38. [Case of langerhans cell histiocytosis treated with cyclosporin].
    Yamaguchi S; Sawamura M; Murayama K; Matsushima T; Tamura S; Murakami H; Narikiyo T; Tsuchiya J
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):303-4. PubMed ID: 7963950
    [No Abstract]   [Full Text] [Related]  

  • 39. An unusual presentation of refractory cutaneous Langerhans cell histiocytosis in an adult.
    Walia SS; Gayer K
    J Drugs Dermatol; 2006 Feb; 5(2):174-7. PubMed ID: 16485886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Langerhans cell histiocytosis].
    Pajunen M; Kousa M
    Duodecim; 1996; 112(24):2399-401. PubMed ID: 10605242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.